Abstract

Remimazolam is an ultrashort-acting benzodiazepine proposed for sedation in gastrointestinal endoscopy. To assess its safety and efficacy, researchers

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call